Mitochondria in vascular disease

Yu, E., Mercer, J.R. and Bennett, M. (2012) Mitochondria in vascular disease. Cardiovascular Research, 95(2), pp. 173-182. (doi: 10.1093/cvr/cvs111) (PMID:22392270)

Full text not currently available from Enlighten.


Mitochondria are often regarded as the powerhouse of the cell by generating the ultimate energy transfer molecule, ATP, which is required for a multitude of cellular processes. However, the role of mitochondria goes beyond their capacity to create molecular fuel, to include the generation of reactive oxygen species, the regulation of calcium, and activation of cell death. Mitochondrial dysfunction is part of both normal and premature ageing, but can contribute to inflammation, cell senescence, and apoptosis. Cardiovascular disease, and in particular atherosclerosis, is characterized by DNA damage, inflammation, cell senescence, and apoptosis. Increasing evidence indicates that mitochondrial damage and dysfunction also occur in atherosclerosis and may contribute to the multiple pathological processes underlying the disease. This review summarizes the normal role of mitochondria, the causes and consequences of mitochondrial dysfunction, and the evidence for mitochondrial damage and dysfunction in vascular disease. Finally, we highlight areas of mitochondrial biology that may have therapeutic targets in vascular disease.

Item Type:Articles
Glasgow Author(s) Enlighten ID:Mercer, Dr John
Authors: Yu, E., Mercer, J.R., and Bennett, M.
College/School:College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health
Journal Name:Cardiovascular Research
Publisher:Oxford University Press
ISSN (Online):1755-3245
Published Online:05 March 2012

University Staff: Request a correction | Enlighten Editors: Update this record